US Needed Simple Pragmatic COVID-19 Trial For Repurposing Candidates, Woodcock Says

Janet Woodcock, John Farley, Sally Seymour of FDA speak with AMA President Susan Bailey.
(Clockwise from bottom right) Acting Commissioner Janet Woodcock, Office of Infectious Disease Director John Farley and Division of Pulmonology, Allergy, Critical Care Director Sally Seymour, and AMA President Susan Bailey discussed COVID-19 therapeutics during an AMA webinar. • Source: screenshot

More from Clinical Trials

More from R&D